Guardant360 Liquid CDx
Plasma cfDNA comprehensive genomic profiling and indication-specific companion diagnostic.
- Developer
- Guardant Health
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- Plasma
- Molecular modality
- DNA mutation
- Current version
- Guardant360 Liquid CDx — P250027 configuration
- Evidence context
- 1 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.